The sensor-laden device with a novel electronic dose counter is currently available for licensing and is expected to enter clinical studies later this year.
GSK will use the sensor in the studies to automatically collect and record data on the inhaler's usage, and wirelessly transmit the data collected.
FDA-approved marketing claims of improved adherence and reduction in exacerbations address key unmet needs in respiratory health.
Safeguard Scientifics led the round, which will be used to accelerate product development, strategic alliances, client services, sales and marketing.
People with any chronic respiratory disease and their family caregivers can get personalized inhaler technique coaching and answers to their questions.
Under the new clearance, the Propeller system can now be used to help predict exacerbations in patients with asthma and COPD.
12Page 2 of 2